Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

National Healthcare (NHC) EPS (Weighted Average and Diluted) (2016 - 2025)

National Healthcare's EPS (Weighted Average and Diluted) history spans 16 years, with the latest figure at $1.57 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 313.16% year-over-year to $1.57; the TTM value through Dec 2025 reached $7.66, up 17.3%, while the annual FY2025 figure was $7.67, 17.46% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $1.57 in Q4 2025 per NHC's latest filing, down from $2.5 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $6.8 in Q2 2021 to a low of -$0.22 in Q3 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is $1.45, with a median of $1.22 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 126.19% in 2021, then surged 525.0% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $1.02 in 2021, then crashed by 59.8% to $0.41 in 2022, then surged by 348.78% to $1.84 in 2023, then crashed by 79.35% to $0.38 in 2024, then surged by 313.16% to $1.57 in 2025.
  • Per Business Quant, the three most recent readings for NHC's EPS (Weighted Average and Diluted) are $1.57 (Q4 2025), $2.5 (Q3 2025), and $1.52 (Q2 2025).